Applied Biology and Corpometria Institute Receive National IRB Approval to Study a Potential Breakthrough Therapy for COVID-19

IRVINE, Calif.–(BUSINESS WIRE)– #COVID19–While studying the genetics of the androgen receptor, a team of scientists discovered a possible breakthrough treatment for COVID-19. The team led by Andy Goren, MD from Applied Biology, Flavio A. Cadegiani, MD, MSc, PhD from Corpometria Institute in Brazil, along with other collaborators, have published their discovery in several medical journals. The manuscript, “What Does Androgenetic Alopecia have to do with COVID-19? An Insight into a Potential New Therapy”